Unmet Needs in Pediatric AD Topicals

Panelists discuss how current topical treatments still leave gaps in managing chronic pediatric atopic dermatitis (AD). Despite progress, many families struggle with inconsistent results, treatment fatigue, or skin irritation. Some therapies address inflammation but not the underlying barrier dysfunction, leading to ongoing flares.

Panelists point out that children and caregivers desire options that are effective, safe for long-term use, and simple to apply. Complex regimens or concerns about adverse effects often undermine adherence. Additionally, emotional support and access to education remain limited for many families.

Improved treatments should combine convenience, tolerability, and durable results to meet real-world needs. The development of innovative, nonsteroidal options signals progress toward this goal.